Canada· CA-DIN-01971409

TRIANAL TABLET

A acetylsalicylsäure, kombinationen mit psycholeptika product containing acetylsalicylic acid + butalbital + caffeine, registered in Canada by LABORATOIRE RIVA INC.. The same ATC class is registered in 3 of our 19 countries.

ATC N02BA71

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTRIANAL TABLETATCN02BA71REGISTER NO.CA-DIN-01971409PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Acetylsalicylsäure, kombinationen mit psycholeptika is registered in 3 of 19 countries.

Countries holding a registration under ATC N02BA71 (acetylsalicylsäure, kombinationen mit psycholeptika), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 2 of them publish a price we can compare per daily dose

Acetylsalicylsäure, kombinationen mit psycholeptika · ATC N02BA71

3 / 19 countries

  • Canada
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
ACETYLSALICYLIC ACID + BUTALBITAL + CAFFEINE
Manufacturer
LABORATOIRE RIVA INC.
Country
Canada (CA)
ATC code
N02BA71
ATC class
Acetylsalicylsäure, Kombinationen mit Psycholeptika
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acetylsalicylsäure, kombinationen mit psycholeptika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acetylsalicylsäure, kombinationen mit psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3224f239-d9b5-4093-821e-37fc2cde783d
GET /v1/drugs/3224f239-d9b5-4093-821e-37fc2cde783d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "01971409",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "N02BA71",
  "schedule": [
    "Schedule G (CDSA IV)"
  ],
  "drug_code": "23671",
  "strengths": [
    "330 MG",
    "50 MG",
    "40 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "ACETYLSALICYLIC ACID",
    "BUTALBITAL",
    "CAFFEINE"
  ],
  "product_categorization": null
}

See everything about acetylsalicylsäure, kombinationen mit psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.